MR [Mindray Medical International] 6-K: Mindray Announces ADS Dividend Record Date for March

[Mindray Announces ADS Dividend Record Date for March 2014 Dividend SHENZHEN, China, March 7, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today that, in accordance with NYSE rules, holders of record of Mindray ADSs at the close of business on March 14, 2014 are entitled to the] [3 EX-99.1 4]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

MR [Mindray Medical International] 6-K: Mindray Announces 2013 Fourth Quarter and Full Year

[Mindray Announces 2013 Fourth Quarter and Full Year Results SHENZHEN, China, March. 3, 2014 — Mindray Medical International Limited (“Mindray”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the fourth quarter and full year ended December 31, 2013. Highlights for Fourth Quarter and Full Year 2013 • Full] [EX-99.1 2]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

MR [Mindray Medical International] 6-K: Mindray Increases its Existing Share Repurchase Program by

[Mindray Increases its Existing Share Repurchase Program by $100 Million Shenzhen, China – March 3, 2014 – Mindray Medical International Limited (“Mindray” or “Company”, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved to increase the size of its previously authorized share repurchase program from US$200 million to] [2 Mindray Medical International Limited]

MR [Mindray Medical International] SC 13G/A: Common Stock 602675100 December 31, 2013 [X] Rule

[Common Stock 602675100 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. CUSIP No.: 602675100 1 NAME]

MR [Mindray Medical International] SC 13G: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,946,754 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172% Item 12: HC Cusip #Y6035S107 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172%]

MR [Mindray Medical International] SC 13G: Item 1: Reporting Person – FMR LLC Item

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 5,946,754 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172% Item 12: HC Cusip #Y6035S107 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 6,130,354 Item 8: 0 Item 9: 6,130,354 Item 11: 7.172%]

MR [Mindray Medical International] SC 13G/A: (Original Filing)

[Common Stock 602675100 December 31, 2013 [X] Rule 13d-1(b) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. CUSIP No.: 602675100 1 NAME]

MR [Mindray Medical International] SC 13G: (Original Filing)

[13G CUSIP No. 602675100 Page 14 of 15 Joint Filing Agreement February 13, 2014 This Agreement may be executed in multiple counterparts, each of which shall constitute an original, one and the same instrument. Commonwealth Bank of Australia Margaret Taylor Company Secretary Colonial Holding Company Limited Michael Venter Director Commonwealth Insurance Holdings Limited Michael Venter Director Colonial First State Group] [13G CUSIP No. 602675100 Page 15 of 15 Item 7 Information The securities being reported on by the reporting persons herein as parent holding companies are owned, or may be deemed to be beneficially owned as follows: Company Type of Company First State Investments (Hong Kong) Limited IA (HK registered) First State Investments International Ltd. IA (US registered) First State] [13G CUSIP No. 602675100 Page 2 of 15 1. Name of reporting person S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Commonwealth Bank of Australia 2. Check the appropriate box if a member of a group ¨ x (a) 3. SEC use only 4. Citizenship or place of organization Australian Capital Territory, Commonwealth of Australia Number of shares beneficially owned]

Skip to toolbar